Cargando…
Acquired Haemophilia A: An Intriguing Disease
Abstract. Acquired Haemophilia A is a rare acquired bleeding disorder caused by Factor VIII autoantibodies, which neutralise FVIII activity. These inhibitors differ from alloantibodies against FVIII, which can occur in congenital Haemophilia A after repeated exposures to plasma-derived or recombinan...
Autores principales: | Mazzucconi, Maria Gabriella, Baldacci, Erminia, Ferretti, Antonietta, Santoro, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340240/ https://www.ncbi.nlm.nih.gov/pubmed/32670523 http://dx.doi.org/10.4084/MJHID.2020.045 |
Ejemplares similares
-
Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case
por: Santoro, Cristina, et al.
Publicado: (2017) -
Dental invasive procedures in von Willebrand disease outpatients treated with high purity FVIII/VWF complex concentrate (Fanhdi®): experience of a single center
por: De Padua, Valeria, et al.
Publicado: (2020) -
Immune thrombocytopenia management during COVID‐19 pandemic: An Italian monocentric experience
por: Lapietra, Gianfranco, et al.
Publicado: (2022) -
Clinical practice of personalized prophylaxis in hemophilia: Illustrations of experiences and benefits from two continents
por: Jackson, Shannon, et al.
Publicado: (2019) -
Direct Oral Anticoagulants in Patients Affected by Major Congenital Thrombophilia
por: Serrao, Alessandra, et al.
Publicado: (2019)